 | • レポートコード：MRC2012B0171 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、心臓マーカー検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。心臓マーカー検査の種類別市場規模（化学発光、免疫蛍光法、ELISA、免疫クロマトグラフィー、その他）、用途別市場規模（製薬会社、試薬メーカー、画像機器プロバイダー、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche Diagnostics、Ortho Clinical Diagnostics、Danaher Corporation、Abbott Laboratories、LSI Medience Corporation、Siemens、Guangzhou Wondfo Biotech、BioMerieux、Alere Inc、Randox Laboratories Ltd、 ・地域別グローバル市場分析 2015年-2020年 ・心臓マーカー検査の北米市場（アメリカ、カナダ、メキシコ） ・心臓マーカー検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・心臓マーカー検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・心臓マーカー検査の南米市場（ブラジル、アルゼンチン） ・心臓マーカー検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学発光、免疫蛍光法、ELISA、免疫クロマトグラフィー、その他 ・用途別分析：製薬会社、試薬メーカー、画像機器プロバイダー、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Cardiac Marker Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.8% in the forecast period of 2020 to 2025 and will expected to reach USD 2986.3 million by 2025, from USD 2478 million in 2019.
The Cardiac Marker Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cardiac Marker Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cardiac Marker Testing market has been segmented into:
Chemiluminescence
Immunofluorescence
ELISA
Immunochromatography
Other
By Application, Cardiac Marker Testing has been segmented into:
Pharmaceutical Companies
Reagents Manufacturers
Imaging Instrument Providers
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cardiac Marker Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Cardiac Marker Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cardiac Marker Testing market.
The report offers in-depth assessment of the growth and other aspects of the Cardiac Marker Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cardiac Marker Testing Market Share Analysis
Cardiac Marker Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cardiac Marker Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cardiac Marker Testing sales, revenue and market share for each player covered in this report.
The major players covered in Cardiac Marker Testing are:
Roche Diagnostics
Ortho Clinical Diagnostics
Danaher Corporation
Abbott Laboratories
LSI Medience Corporation
Siemens
Guangzhou Wondfo Biotech
BioMerieux
Alere Inc
Randox Laboratories Ltd
Table of Contents
1 Cardiac Marker Testing Market Overview
1.1 Product Overview and Scope of Cardiac Marker Testing
1.2 Classification of Cardiac Marker Testing by Type
1.2.1 Global Cardiac Marker Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cardiac Marker Testing Revenue Market Share by Type in 2019
1.2.3 Chemiluminescence
1.2.4 Immunofluorescence
1.2.5 ELISA
1.2.6 Immunochromatography
1.2.7 Other
1.3 Global Cardiac Marker Testing Market by Application
1.3.1 Overview: Global Cardiac Marker Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical Companies
1.3.3 Reagents Manufacturers
1.3.4 Imaging Instrument Providers
1.3.5 Other
1.4 Global Cardiac Marker Testing Market by Regions
1.4.1 Global Cardiac Marker Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cardiac Marker Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cardiac Marker Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cardiac Marker Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cardiac Marker Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cardiac Marker Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cardiac Marker Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche Diagnostics SWOT Analysis
2.1.4 Roche Diagnostics Product and Services
2.1.5 Roche Diagnostics Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ortho Clinical Diagnostics
2.2.1 Ortho Clinical Diagnostics Details
2.2.2 Ortho Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ortho Clinical Diagnostics SWOT Analysis
2.2.4 Ortho Clinical Diagnostics Product and Services
2.2.5 Ortho Clinical Diagnostics Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Danaher Corporation
2.3.1 Danaher Corporation Details
2.3.2 Danaher Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Danaher Corporation SWOT Analysis
2.3.4 Danaher Corporation Product and Services
2.3.5 Danaher Corporation Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories SWOT Analysis
2.4.4 Abbott Laboratories Product and Services
2.4.5 Abbott Laboratories Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 LSI Medience Corporation
2.5.1 LSI Medience Corporation Details
2.5.2 LSI Medience Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 LSI Medience Corporation SWOT Analysis
2.5.4 LSI Medience Corporation Product and Services
2.5.5 LSI Medience Corporation Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Siemens
2.6.1 Siemens Details
2.6.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Siemens SWOT Analysis
2.6.4 Siemens Product and Services
2.6.5 Siemens Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Guangzhou Wondfo Biotech
2.7.1 Guangzhou Wondfo Biotech Details
2.7.2 Guangzhou Wondfo Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Guangzhou Wondfo Biotech SWOT Analysis
2.7.4 Guangzhou Wondfo Biotech Product and Services
2.7.5 Guangzhou Wondfo Biotech Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 BioMerieux
2.8.1 BioMerieux Details
2.8.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BioMerieux SWOT Analysis
2.8.4 BioMerieux Product and Services
2.8.5 BioMerieux Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Alere Inc
2.9.1 Alere Inc Details
2.9.2 Alere Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Alere Inc SWOT Analysis
2.9.4 Alere Inc Product and Services
2.9.5 Alere Inc Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Randox Laboratories Ltd
2.10.1 Randox Laboratories Ltd Details
2.10.2 Randox Laboratories Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Randox Laboratories Ltd SWOT Analysis
2.10.4 Randox Laboratories Ltd Product and Services
2.10.5 Randox Laboratories Ltd Cardiac Marker Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cardiac Marker Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cardiac Marker Testing Players Market Share
3.2.2 Top 10 Cardiac Marker Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cardiac Marker Testing Revenue and Market Share by Regions
4.2 North America Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
4.5 South America Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
5 North America Cardiac Marker Testing Revenue by Countries
5.1 North America Cardiac Marker Testing Revenue by Countries (2015-2020)
5.2 USA Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
6 Europe Cardiac Marker Testing Revenue by Countries
6.1 Europe Cardiac Marker Testing Revenue by Countries (2015-2020)
6.2 Germany Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
6.3 UK Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
6.4 France Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cardiac Marker Testing Revenue by Countries
7.1 Asia-Pacific Cardiac Marker Testing Revenue by Countries (2015-2020)
7.2 China Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
7.5 India Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
8 South America Cardiac Marker Testing Revenue by Countries
8.1 South America Cardiac Marker Testing Revenue by Countries (2015-2020)
8.2 Brazil Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cardiac Marker Testing by Countries
9.1 Middle East & Africa Cardiac Marker Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cardiac Marker Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Cardiac Marker Testing Market Forecast by Type (2019-2024)
10.3 Chemiluminescence Revenue Growth Rate (2015-2025)
10.4 Immunofluorescence Revenue Growth Rate (2015-2025)
10.5 ELISA Revenue Growth Rate (2015-2025)
10.6 Immunochromatography Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Cardiac Marker Testing Market Segment by Application
11.1 Global Cardiac Marker Testing Revenue Market Share by Application (2015-2020)
11.2 Cardiac Marker Testing Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Companies Revenue Growth (2015-2020)
11.4 Reagents Manufacturers Revenue Growth (2015-2020)
11.5 Imaging Instrument Providers Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Cardiac Marker Testing Market Size Forecast (2021-2025)
12.1 Global Cardiac Marker Testing Market Size Forecast (2021-2025)
12.2 Global Cardiac Marker Testing Market Forecast by Regions (2021-2025)
12.3 North America Cardiac Marker Testing Revenue Market Forecast (2021-2025)
12.4 Europe Cardiac Marker Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cardiac Marker Testing Revenue Market Forecast (2021-2025)
12.6 South America Cardiac Marker Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cardiac Marker Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cardiac Marker Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cardiac Marker Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cardiac Marker Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cardiac Marker Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Diagnostics Corporate Information, Location and Competitors
Table 6. Roche Diagnostics Cardiac Marker Testing Major Business
Table 7. Roche Diagnostics Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 8. Roche Diagnostics SWOT Analysis
Table 9. Roche Diagnostics Cardiac Marker Testing Product and Solutions
Table 10. Roche Diagnostics Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Ortho Clinical Diagnostics Corporate Information, Location and Competitors
Table 12. Ortho Clinical Diagnostics Cardiac Marker Testing Major Business
Table 13. Ortho Clinical Diagnostics Cardiac Marker Testing Total Revenue (USD Million) (2018-2019)
Table 14. Ortho Clinical Diagnostics SWOT Analysis
Table 15. Ortho Clinical Diagnostics Cardiac Marker Testing Product and Solutions
Table 16. Ortho Clinical Diagnostics Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Danaher Corporation Corporate Information, Location and Competitors
Table 18. Danaher Corporation Cardiac Marker Testing Major Business
Table 19. Danaher Corporation Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 20. Danaher Corporation SWOT Analysis
Table 21. Danaher Corporation Cardiac Marker Testing Product and Solutions
Table 22. Danaher Corporation Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott Laboratories Corporate Information, Location and Competitors
Table 24. Abbott Laboratories Cardiac Marker Testing Major Business
Table 25. Abbott Laboratories Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 26. Abbott Laboratories SWOT Analysis
Table 27. Abbott Laboratories Cardiac Marker Testing Product and Solutions
Table 28. Abbott Laboratories Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. LSI Medience Corporation Corporate Information, Location and Competitors
Table 30. LSI Medience Corporation Cardiac Marker Testing Major Business
Table 31. LSI Medience Corporation Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 32. LSI Medience Corporation SWOT Analysis
Table 33. LSI Medience Corporation Cardiac Marker Testing Product and Solutions
Table 34. LSI Medience Corporation Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Siemens Corporate Information, Location and Competitors
Table 36. Siemens Cardiac Marker Testing Major Business
Table 37. Siemens Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 38. Siemens SWOT Analysis
Table 39. Siemens Cardiac Marker Testing Product and Solutions
Table 40. Siemens Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Guangzhou Wondfo Biotech Corporate Information, Location and Competitors
Table 42. Guangzhou Wondfo Biotech Cardiac Marker Testing Major Business
Table 43. Guangzhou Wondfo Biotech Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 44. Guangzhou Wondfo Biotech SWOT Analysis
Table 45. Guangzhou Wondfo Biotech Cardiac Marker Testing Product and Solutions
Table 46. Guangzhou Wondfo Biotech Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. BioMerieux Corporate Information, Location and Competitors
Table 48. BioMerieux Cardiac Marker Testing Major Business
Table 49. BioMerieux Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 50. BioMerieux SWOT Analysis
Table 51. BioMerieux Cardiac Marker Testing Product and Solutions
Table 52. BioMerieux Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Alere Inc Corporate Information, Location and Competitors
Table 54. Alere Inc Cardiac Marker Testing Major Business
Table 55. Alere Inc Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 56. Alere Inc SWOT Analysis
Table 57. Alere Inc Cardiac Marker Testing Product and Solutions
Table 58. Alere Inc Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Randox Laboratories Ltd Corporate Information, Location and Competitors
Table 60. Randox Laboratories Ltd Cardiac Marker Testing Major Business
Table 61. Randox Laboratories Ltd Cardiac Marker Testing Total Revenue (USD Million) (2017-2018)
Table 62. Randox Laboratories Ltd SWOT Analysis
Table 63. Randox Laboratories Ltd Cardiac Marker Testing Product and Solutions
Table 64. Randox Laboratories Ltd Cardiac Marker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Cardiac Marker Testing Revenue (Million USD) by Players (2015-2020)
Table 66. Global Cardiac Marker Testing Revenue Share by Players (2015-2020)
Table 67. Global Cardiac Marker Testing Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Cardiac Marker Testing Revenue Market Share by Regions (2015-2020)
Table 69. North America Cardiac Marker Testing Revenue by Countries (2015-2020)
Table 70. North America Cardiac Marker Testing Revenue Market Share by Countries (2015-2020)
Table 71. Europe Cardiac Marker Testing Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Cardiac Marker Testing Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Cardiac Marker Testing Revenue by Countries (2015-2020)
Table 74. South America Cardiac Marker Testing Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Cardiac Marker Testing Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Cardiac Marker Testing Revenue Market Share by Countries (2015-2020)
Table 77. Global Cardiac Marker Testing Revenue (Million USD) by Type (2015-2020)
Table 78. Global Cardiac Marker Testing Revenue Share by Type (2015-2020)
Table 79. Global Cardiac Marker Testing Revenue Forecast by Type (2021-2025)
Table 80. Global Cardiac Marker Testing Revenue by Application (2015-2020)
Table 81. Global Cardiac Marker Testing Revenue Share by Application (2015-2020)
Table 82. Global Cardiac Marker Testing Revenue Forecast by Application (2021-2025)
Table 83. Global Cardiac Marker Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cardiac Marker Testing Picture
Figure 2. Global Cardiac Marker Testing Revenue Market Share by Type in 2019
Figure 3. Chemiluminescence Picture
Figure 4. Immunofluorescence Picture
Figure 5. ELISA Picture
Figure 6. Immunochromatography Picture
Figure 7. Other Picture
Figure 8. Cardiac Marker Testing Revenue Market Share by Application in 2019
Figure 9. Pharmaceutical Companies Picture
Figure 10. Reagents Manufacturers Picture
Figure 11. Imaging Instrument Providers Picture
Figure 12. Other Picture
Figure 13. Global Cardiac Marker Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Cardiac Marker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Cardiac Marker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Cardiac Marker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Cardiac Marker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Cardiac Marker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Cardiac Marker Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Cardiac Marker Testing Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Cardiac Marker Testing Revenue Market Share in 2019
Figure 22. Global Top 10 Players Cardiac Marker Testing Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Cardiac Marker Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Cardiac Marker Testing Revenue Market Share by Regions (2015-2020)
Figure 26. Global Cardiac Marker Testing Revenue Market Share by Regions in 2018
Figure 27. North America Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 28. Europe Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 30. South America Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 32. North America Cardiac Marker Testing Revenue Market Share by Countries (2015-2020)
Figure 33. North America Cardiac Marker Testing Revenue Market Share by Countries in 2019
Figure 34. USA Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 35. Canada Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 37. Europe Cardiac Marker Testing Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Cardiac Marker Testing Revenue Market Share by Countries in 2019
Figure 39. Germany Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 40. UK Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 41. France Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 42. Russia Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 43. Italy Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Cardiac Marker Testing Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Cardiac Marker Testing Revenue Market Share by Countries in 2019
Figure 46. China Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 47. Japan Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 48. Korea Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 49. India Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 51. South America Cardiac Marker Testing Revenue Market Share by Countries (2015-2020)
Figure 52. South America Cardiac Marker Testing Revenue Market Share by Countries in 2019
Figure 53. Brazil Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Cardiac Marker Testing Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Cardiac Marker Testing Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 58. UAE Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Cardiac Marker Testing Revenue and Growth Rate (2015-2020)
Figure 61. Global Cardiac Marker Testing Revenue Share by Type (2015-2020)
Figure 62. Global Cardiac Marker Testing Revenue Share by Type in 2019
Figure 63. Global Cardiac Marker Testing Market Share Forecast by Type (2021-2025)
Figure 64. Global Chemiluminescence Revenue Growth Rate (2015-2020)
Figure 65. Global Immunofluorescence Revenue Growth Rate (2015-2020)
Figure 66. Global ELISA Revenue Growth Rate (2015-2020)
Figure 67. Global Immunochromatography Revenue Growth Rate (2015-2020)
Figure 68. Global Other Revenue Growth Rate (2015-2020)
Figure 69. Global Cardiac Marker Testing Revenue Share by Application (2015-2020)
Figure 70. Global Cardiac Marker Testing Revenue Share by Application in 2019
Figure 71. Global Cardiac Marker Testing Market Share Forecast by Application (2021-2025)
Figure 72. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 73. Global Reagents Manufacturers Revenue Growth Rate (2015-2020)
Figure 74. Global Imaging Instrument Providers Revenue Growth Rate (2015-2020)
Figure 75. Global Other Revenue Growth Rate (2015-2020)
Figure 76. Global Cardiac Marker Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Cardiac Marker Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Cardiac Marker Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Cardiac Marker Testing Revenue Market Forecast (2021-2025)
Figure 80. Europe Cardiac Marker Testing Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Cardiac Marker Testing Revenue Market Forecast (2021-2025)
Figure 82. South America Cardiac Marker Testing Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Cardiac Marker Testing Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
肝炎マーカー検査の世界市場（～2026年） The liver is an essential organ of the body which helps in digestion of food, removal of toxins from the blood, and storage of energy in the body. Inflammation of the liver usually due to viral infections, excessive alcohol consumption, and drugs can cause hepatitis. Hepatitis can be classified as h…- 腫瘍マーカー検査の世界市場（～2026年） The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagn…
- ヘルペスマーカー検査の世界市場（～2026年） Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial disea…
- 分子量マーカーの世界市場（～2026年） Molecular weight markers are used to calculate sample molecular weights in the medical research arena. In addition, these markers play a vital role in the monitoring of the progress of an electrophoretic run in separation and analysis of macromolecules. Molecular weight markers include RNA, DNA, and…
- 細胞表面マーカー検出の世界市場（～2026年） Cell surface markers are also known as cell surface antigen serves as monograms to help identify and classify cells. There is an increase in demand for the cell surface marker detection market owing to the advancements in high-throughput tools and techniques used for cytological analysis. Market Ana…